References
[1]. Gilpin, R. (2003). The Challenge of Global Capitalism: The World Economy in the 21 st Century. Globalization and the Poor: Exploitation or Equalizer, 61-68.
[2]. Cyr, A. I. (2001). Guides to globalization. Orbis, 45(2), 295-295.
[3]. Sutcliffe, B., & Glyn, A. (1999). Still underwhelmed: indicators of globalization and their misinterpretation. Review of Radical Political Economics, 31(1), 111-131.
[4]. Sitas F, Parkin M, Chirenje Z, Stein L, Mqoqi N, Wabinga H. Disease and Mortality in Sub- Saharan Africa. Washinton DC: The International Bank for Reconstruction and Development/The World Bank. 2006
[5]. Mudie, K., Jin, M. M., Tan, L. K., Addo, J., dos-Santos-Silva, I., Quint, J., ... & Perel, P. (2019). Non-communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies. Journal of global health, 9(2).
[6]. Marquez, P. V., & Farrington, J. L. (2013). The challenge of non-communicable diseases and road traffic injuries in sub-Saharan Africa: an overview.
[7]. Bygbjerg, I. C. (2012). Double burden of noncommunicable and infectious diseases in developing countries. Science, 337(6101), 1499-1501.
[8]. Mayosi, B. M., Flisher, A. J., Lalloo, U. G., Sitas, F., Tollman, S. M., & Bradshaw, D. (2009). The burden of non-communicable diseases in South Africa. The lancet, 374(9693), 934-947.
[9]. Holmes, M. D., Dalal, S., Volmink, J., Adebamowo, C. A., Njelekela, M., Fawzi, W. W., ... & Adami, H. O. (2010). Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med, 7(5), e1000244.
[10]. Bonita, R., Winkelmann, R., Douglas, K. A., & de Courten, M. (2003). The WHO Stepwise approach to surveillance (STEPS) of non-communicable disease risk factors. In Global behavioral risk factor surveillance (pp. 9-22). Springer, Boston, MA.
[11]. Boutayeb, A. (2010). The impact of infectious diseases on the development of Africa. Handbook of disease burdens and quality of life measures, 1171.
[12]. World Health Organization. (2002). Global defence against the infectious disease threat. World Health Organization.
[13]. Buor, D., & Bream, K. (2004). An analysis of the determinants of maternal mortality in sub- Saharan Africa. Journal of Women's Health, 13(8), 926-938.
[14]. Coulibaly, I. (2005). The impact of HIV/AIDS on the labour force in Sub-Saharan Africa: A preliminary assessment. Geneva: International Labor Office.
[15]. De La Fuente, A., Jacoby, H. G., & Lawin, K. G. (2020). Impact of the West African Ebola epidemic on agricultural production and rural welfare: Evidence from Liberia. Journal of African Economies, 29(5), 454-474.
[16]. Rutmanis, R. (2005). „Foreign Players and the Globalization of Basketball “.
[17]. Mercer, D. C., Page, B., & Evans, M. (Eds.). (2013). Development and the African diaspora: place and the politics of home. Zed Books Ltd..
[18]. Courtright, P. (2012). Childhood cataract in sub-Saharan Africa. Saudi Journal of Ophthalmology, 26(1), 3-6.
[19]. Warria, A. (2018). Girls' innocence and futures stolen: The cultural practice of sexual cleansing in Malawi. Children and Youth Services Review, 91, 298-303.
[20]. Garve, R., Garve, M., Türp, J. C., Fobil, J. N., & Meyer, C. G. (2017). Scarification in sub- Saharan Africa: Social skin, remedy and medical import. Tropical Medicine & International Health, 22(6), 708-715.
[21]. Kew, MC, Reis, P., Macnab, GM, Seftel, HC & Bersohn, I. (1973). The witch-doctor and tribal scarification of the skin and the hepatitis B antigen. South African Medical Journal, 47(50), 2419-2420.
[22]. Alabi, G. O., & George, A. O. (1989). Cutaneous sarcoidosis and tribal scarifications in West Africa. International journal of dermatology, 28(1), 29-31.
[23]. Tabuti, J. R., Hassen, I. E., Pateh, U. U., & Mahomoodally, M. F. (2014). Recent advances towards validating efficacy and safety of African traditional medicines.